Aim 3 Particle Swarm Optimization PIGD
Parkinson's Disease and Parkinsonism
About this trial
This is an interventional treatment trial for Parkinson's Disease and Parkinsonism
Eligibility Criteria
Diagnosis of Parkinson's Disease Bilateral DBS in STN or GP At least 3 months after lead implantation Montreal Cognitive Assessment (MoCA): MoCA=23+ OR: If MoCA score is 23 or less, UBACC will be performed to ensure capacity to consent. If UBACC results are unclear, the MacCAT-CR will be performed. Failed or unclear MacCAT-CR results will exclude the study candidate. Between 18-85 years of age Has undergone pre-operative 7T MRI (as part of protocol #1210M22183 or standard-of-care) and post-operative CT imaging (standard of care). 8.2 Exclusion Criteria: Inability to walk in the off-med, off-stimulation condition (even with safety harness) Gait impaired significantly by a condition other than PD Breaks or shorts in active contacts IPG battery nearing end of life (in patients with primary-cell IPGs) Females who are nursing or pregnant
Sites / Locations
- University of MinnesotaRecruiting